Table 2.

Results from follow‐up genotyping

	NO APOE‐ε4a			APOE‐ε4b
SNV	BETA	SE	P	BETA	SE	P	GENE
1‐207680070‐C‐T	0.13	0.21	5.2E‐01	0.15	0.21	4.6E‐01	CR1
1‐207741237‐C‐T	1.61	0.99	1.0E‐01	1.60	0.96	9.6E‐02	CR1
7‐29035428‐C‐T	0.82	0.44	6.3E‐02	0.80	0.43	6.2E‐02	CPVL
7‐30876316‐C‐T	−0.58	0.42	1.7E‐01	−0.50	0.41	2.3E‐01	FAM188B
7‐31682771‐C‐T	0.87	1.25	4.9E‐01	0.86	1.26	4.9E‐01	CCDC129
7‐91630531‐C‐T	1.75	0.86	4.1E‐02	1.84	0.88	3.8E‐02	AKAP9
7‐91667736‐A‐G	0.35	0.35	3.2E‐01	0.35	0.38	3.5E‐01	AKAP9
7‐143091417‐C‐T	0.18	0.68	8.0E‐01	0.19	0.67	7.7E‐01	EPHA1
11‐60703423‐G‐A	0.06	0.45	8.9E‐01	0.00	0.43	1.0E+00	TMEM132A
11‐61015721‐G‐A	0.93	0.54	8.5E‐02	0.81	0.54	1.3E‐01	PGA5
11‐61120560‐G‐A	‐0.08	0.58	8.9E‐01	‐0.07	0.57	9.0E‐01	CYB561A3
11‐61250246‐G‐A	0.10	0.50	8.4E‐01	‐0.02	0.47	9.6E‐01	PPP1R32
11‐61546888‐G‐A	‐0.55	0.26	3.8E‐02	‐0.49	0.26	5.9E‐02	MYRF
11‐62286666‐C‐T	0.72	0.73	3.2E‐01	0.75	0.75	3.2E‐01	AHNAK
11‐62343562‐G‐C	1.09	0.50	2.8E‐02	0.96	0.51	5.9E‐02	ASRGL1
11‐62344743‐C‐T	0.72	0.73	3.2E‐01	0.75	0.75	3.2E‐01	MIR3654
11‐62400108‐G‐A	‐0.31	0.36	4.0E‐01	‐0.26	0.36	4.7E‐01	GANAB
11‐62886345‐G‐A	0.21	0.54	6.9E‐01	0.24	0.54	6.6E‐01	SLC3A2
14‐93142861‐T‐C	0.29	0.42	5.0E‐01	0.31	0.42	4.6E‐01	RIN3
19‐1057919‐C‐T	0.62	0.70	3.8E‐01	0.58	0.67	3.9E‐01	ABCA7

^aModel‐ LOAD ~ Gene + Age + Sex + proportion of African ancestry + proportion of Native American Ancestry + First ten principal components.

^bModel‐ LOAD ~ Gene + Age + Sex + number of APOE ε4 alleles + proportion of African ancestry + proportion of Native American Ancestry + First ten principal components. (nominally significant variants are highlighted in bold).